A detailed history of Investment Advisory Group, LLC transactions in Repligen Corp stock. As of the latest transaction made, Investment Advisory Group, LLC holds 1,721 shares of RGEN stock, worth $250,474. This represents 0.09% of its overall portfolio holdings.

Number of Shares
1,721
Previous 1,720 0.06%
Holding current value
$250,474
Previous $216,000 18.52%
% of portfolio
0.09%
Previous 0.08%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$119.79 - $167.35 $119 - $167
1 Added 0.06%
1,721 $256,000
Q2 2024

Jul 31, 2024

SELL
$120.0 - $182.95 $360 - $548
-3 Reduced 0.17%
1,720 $216,000
Q1 2024

Apr 29, 2024

BUY
$170.78 - $208.42 $512 - $625
3 Added 0.17%
1,723 $316,000
Q4 2023

Jan 30, 2024

SELL
$114.17 - $185.35 $114 - $185
-1 Reduced 0.06%
1,720 $309,000
Q3 2023

Oct 16, 2023

BUY
$138.78 - $176.51 $138 - $176
1 Added 0.06%
1,721 $273,000
Q4 2021

Feb 11, 2022

BUY
$247.59 - $304.47 $425,854 - $523,688
1,720 New
1,720 $333,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.08B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Investment Advisory Group, LLC Portfolio

Follow Investment Advisory Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Investment Advisory Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Investment Advisory Group, LLC with notifications on news.